According to the World Health Organization (WHO), around 48.5 million couples worldwide were unable to conceive child in 2010. Furthermore, increasing risk of fatal genetic, hereditary, and chromosomal diseases such as duchenne muscular dystrophy, down syndrome, cystic fibrosis, triploidy, and thalassemia promote patients to opt for PGD thereby, boosting the market growth worldwide. Furthermore, increase in awareness about innovative and advanced application of PGD in the developing countries such as China and India offers enormous opportunities for the market growth. Rise in awareness about the various genetic disorders and chromosomal abnormalities have increased the demand of diagnostic procedures including PGD.
The global preimplantation genetics diagnosis (pgd) market was valued at $81,520.20 thousand in 2020, and is projected to reach $217,190.00 thousand by 2030, growing at a CAGR of 10.4% from 2021 to 2030.
Request The Free Sample PDF Of This Report:
https://www.alliedmarketresearch.com/request-sample/1470
“People are anxious over potential harmful effects related to chromosomal, genetic, and hereditary, leads to infertility-related problems such as PCOS and low sperm count disorders.” says Hemali Narkhede, Manager, Healthcare Research at Allied Market Research “PGD helps in preventing inheritance of diseases and thereby eliminating the chances of pregnancy termination,” she further added.
The PGD market has witnessed significant growth in the past decade, owing to advantages, including capability to detect embryos with genetic defects and prevention of unhealthy births. A number of players in the PGD industry are expanding their business to strengthen their foothold in the global market. By test type, the chromosomal abnormalities segment dominated the PGD market in 2020, in terms of revenue. This is attributed to increase in demand for PGD in developing countries.
The key players profiled in the PGD market report include Agilent Technologies, Inc., CeGaT GmbH, Illumina Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Natera Inc., PacGenomics, PerkinElmer, Inc., Quest Diagnostics Inc., and Reproductive Genetic Innovations (RGI).
KEY FINDINGS OF THE STUDY
- The report provides an extensive analysis of the current and emerging preimplantation genetics diagnosis market trends and dynamics.
- Depending on test type, the chromosomal abnormalities dominated the PGD market, in terms of revenue in 2020 and the single gene disorders segment is projected to grow at a significant CAGR during the forecast period.
- Asia-Pacific is projected to register highest growth rate in the coming years.
- The key players within the PGD market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of the PGD industry.
𝗚𝗲𝘁 𝗱𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗶𝗺𝗽𝗮𝗰𝘁 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀@ 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗙𝗼𝗿 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻: https://www.alliedmarketresearch.com/request-for-customization/1470?reqfor=covid
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com